在头癌中CD276表达的临床病理特征和预后价值:元分析

Hang Su1, Ning Li2, Zitong Chen2

  • 1Department of Thyroid and Breast Surgery, Hebei General Hospital, Shijiazhuang, China; Graduate School, North China University of Science and Technology, Tangshan, China.

概括

CD276的表达与性别,淋巴结状况和头癌的TNM阶段有关. 这种生物标志物还预测了更糟糕的预后,表明了新的免疫疗法的潜力.

相关概念视频